JP2011513304A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011513304A5 JP2011513304A5 JP2010548648A JP2010548648A JP2011513304A5 JP 2011513304 A5 JP2011513304 A5 JP 2011513304A5 JP 2010548648 A JP2010548648 A JP 2010548648A JP 2010548648 A JP2010548648 A JP 2010548648A JP 2011513304 A5 JP2011513304 A5 JP 2011513304A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- rosacea
- item
- dapsone
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 14
- 201000004700 rosacea Diseases 0.000 claims 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 claims 4
- 241001303601 Rosacea Species 0.000 claims 4
- 229960000860 dapsone Drugs 0.000 claims 4
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims 4
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 claims 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims 4
- 229940085237 carbomer-980 Drugs 0.000 claims 2
- 230000003902 lesion Effects 0.000 claims 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims 2
- 229960002216 methylparaben Drugs 0.000 claims 2
- 239000008213 purified water Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 206010033733 Papule Diseases 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2008/002549 WO2009108147A1 (en) | 2008-02-27 | 2008-02-27 | Dapsone to treat rosascea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011513304A JP2011513304A (ja) | 2011-04-28 |
| JP2011513304A5 true JP2011513304A5 (enExample) | 2011-06-16 |
Family
ID=41016365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010548648A Pending JP2011513304A (ja) | 2008-02-27 | 2008-02-27 | 酒さを処置するためのダプソン |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8586010B2 (enExample) |
| EP (1) | EP2249765B1 (enExample) |
| JP (1) | JP2011513304A (enExample) |
| AU (1) | AU2008351422A1 (enExample) |
| BR (1) | BRPI0822264A2 (enExample) |
| CA (1) | CA2714674A1 (enExample) |
| ES (1) | ES2775825T3 (enExample) |
| WO (1) | WO2009108147A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110152379A1 (en) * | 2008-07-25 | 2011-06-23 | Sang Chul Park | Composition for control of aging and/or extension of life, containing dapsone as active ingredient |
| MX2009004635A (es) * | 2009-04-29 | 2010-10-29 | Univ Autonoma Metropolitana | Formas farmaceúticas solubles de la n,n´-diamino-difenilsulfona para su uso óptimo en el tratamiento de diversas enfermedades. |
| JP5908884B2 (ja) * | 2010-03-15 | 2016-04-26 | ヴァージニア コモンウェルス ユニヴァーシティＶｉｒｇｉｎｉａ Ｃｏｍｍｏｎｗｅａｌｔｈ Ｕｎｉｖｅｒｓｉｔｙ | 気道炎症及び粘液線毛輸送機能異常治療用のエアロゾル化したダプソン |
| KR101875705B1 (ko) | 2011-12-07 | 2018-07-06 | 삼성전자주식회사 | 디아미노디페닐술폰을 포함하는 근육 소모 관련 질환의 예방 또는 치료용 약학적 조성물 |
| US11039962B2 (en) | 2012-04-02 | 2021-06-22 | TurnCare, Inc. | Non-invasive pressure-mitigation apparatuses for improving blood flow and associated systems and methods |
| US20130255699A1 (en) | 2012-04-02 | 2013-10-03 | TurnCare, Inc. | Patient-orienting alternating pressure decubitus prevention support apparatus |
| DK2922528T3 (en) * | 2012-11-20 | 2017-09-18 | Allergan Inc | TOPICAL DAPSON AND DAPSON / ADAPALEN COMPOSITIONS AND PROCEDURES FOR USE THEREOF |
| US12178949B2 (en) | 2020-10-09 | 2024-12-31 | TurnCare, Inc. | Pressure-mitigation apparatuses for improved treatment of immobilized patients and associated systems and methods |
| US12016812B2 (en) | 2020-10-09 | 2024-06-25 | TurnCare, Inc. | Pressure-mitigation apparatuses for improved treatment of respiratory illnesses and associated systems and methods |
| JPWO2022269665A1 (enExample) * | 2021-06-21 | 2022-12-29 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3419009A1 (de) | 1984-05-22 | 1985-11-28 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel |
| DE3603577A1 (de) | 1986-02-06 | 1987-08-13 | Joachim K Prof Dr Seydel | Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit |
| US5733572A (en) | 1989-12-22 | 1998-03-31 | Imarx Pharmaceutical Corp. | Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles |
| US5863560A (en) | 1996-09-11 | 1999-01-26 | Virotex Corporation | Compositions and methods for topical application of therapeutic agents |
| US20030157036A1 (en) * | 2002-02-20 | 2003-08-21 | Osborne David W. | Topical dapsone for the treatment of acne |
| US6056954A (en) | 1997-10-31 | 2000-05-02 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses |
| US6248324B1 (en) | 1997-10-31 | 2001-06-19 | Vincent Fischetti | Bacterial phage associated lysing enzymes for treating dermatological infections |
| US6254866B1 (en) | 1997-10-31 | 2001-07-03 | New Horizons Diagnostics Corporation | Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract |
| US6277399B1 (en) | 1997-10-31 | 2001-08-21 | New Horizon Diagnostics Corporation | Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
| US6056955A (en) | 1999-09-14 | 2000-05-02 | Fischetti; Vincent | Topical treatment of streptococcal infections |
| WO2002085387A2 (en) * | 2001-04-23 | 2002-10-31 | Nucryst Pharmaceuticals Corp. | A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent ans their use in the treatment of inflammatory skin conditions |
| US20060204526A1 (en) * | 2003-08-13 | 2006-09-14 | Lathrop Robert W | Emulsive composition containing Dapsone |
| AU2004264964A1 (en) * | 2003-08-13 | 2005-02-24 | Qlt Usa, Inc. | Emulsive composition containing dapsone |
| FR2866570B1 (fr) * | 2004-02-20 | 2007-08-24 | Galderma Res & Dev | Utilisation du metronidazole pour la preparation d'une composition pharmaceutique destinee a traiter une inflammation cutanee |
| WO2007002447A2 (en) * | 2005-06-23 | 2007-01-04 | Bioform Medical, Inc. | Compositions for treating rosacea |
| PT2056813E (pt) * | 2006-08-16 | 2013-08-23 | Amderma Pharmaceuticals Llc | Compostos de 2,5-di-hidroxibenzeno para o tratamento da rosácea |
-
2008
- 2008-02-27 ES ES08726129T patent/ES2775825T3/es active Active
- 2008-02-27 CA CA2714674A patent/CA2714674A1/en not_active Abandoned
- 2008-02-27 JP JP2010548648A patent/JP2011513304A/ja active Pending
- 2008-02-27 WO PCT/US2008/002549 patent/WO2009108147A1/en not_active Ceased
- 2008-02-27 AU AU2008351422A patent/AU2008351422A1/en not_active Abandoned
- 2008-02-27 EP EP08726129.3A patent/EP2249765B1/en active Active
- 2008-02-27 BR BRPI0822264-9A2A patent/BRPI0822264A2/pt not_active Application Discontinuation
- 2008-02-27 US US12/305,413 patent/US8586010B2/en active Active
-
2013
- 2013-10-25 US US14/063,841 patent/US9504661B2/en active Active
-
2016
- 2016-11-28 US US15/362,099 patent/US20170071882A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011513304A5 (enExample) | ||
| WO2012015810A3 (en) | Pharmaceutical compositions containing pemetrexed having extended storage stability | |
| JP5882260B2 (ja) | ペプチドおよびその使用 | |
| BRPI0414581A (pt) | derivados de benzimidazol: preparação e aplicações farmacêuticas | |
| JP2009544722A5 (enExample) | ||
| WO2006076620A3 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
| JP2008533007A5 (enExample) | ||
| CL2012001056A1 (es) | Compuestos derivados de cromenona sustituidos, inhibidores de enzimas pi 3 quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion de trastornos de proliferacion celular, tales como tumores enfermedades inflamatorias y fibroticas, asma, diabetes insulinodependiente, entre otras. | |
| CN115697994A (zh) | 稠合喹唑啉类衍生物、其制备方法及其在医药上的应用 | |
| WO2009010416A3 (en) | Inhibitors of 11b-hydroxysteroid dehydrogenase | |
| WO2008143240A1 (ja) | 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法 | |
| NO20100301L (no) | Forbedrete brimonidinsammensetninger for behandling av erytem | |
| WO2010084115A3 (en) | Antiviral agents | |
| WO2009109613A3 (en) | 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 | |
| CA2672452A1 (en) | Tannate salt of rasagiline | |
| BR112014009910A2 (pt) | formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico | |
| AR079706A1 (es) | Composiciones, metodos para el tratamiento de enfermedades oculares relacionadas con la angiogenesis y uso | |
| JP2012521351A5 (enExample) | ||
| WO2006101858B1 (en) | Alpha-helix mimetics and methods relating to the treatment of fibrosis | |
| WO2009109654A3 (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxcr1 and p40 | |
| Badavath et al. | Design, in-silico docking and predictive ADME properties of novel pyrazoline derivatives with selective human MAO inhibitory activity | |
| WO2007121545A8 (en) | S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions | |
| RU2007129571A (ru) | Композиции на основе солей гиалуроновой кислоты для лечения эпителиальных повреждений | |
| AR056552A1 (es) | Uso de un agonista beta-3 para el tratamiento de trastornos renales y vesiculares en pacientes con lesiones de la medula espinal | |
| UA92009C2 (ru) | Производные 4-фенил-5-оксо-1,4,5,6,7,8-гексагидрохинолина для лечения бесплодия |